{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T20:16:39Z","timestamp":1774728999306,"version":"3.50.1"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T00:00:00Z","timestamp":1621987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p><jats:bold>Purpose:<\/jats:bold> The aims of this study were to develop and validate a novel nomogram to predict thromboembolism (TE) in gastric cancer (GC) patients receiving chemotherapy and to test its predictive ability.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> This retrospective study included 544 GC patients who received chemotherapy as the initial treatment at two medical centers. Among the 544 GC patients who received chemotherapy, 275 and 137 patients in the First Affiliated Hospital of Nanchang University from January 2014 to March 2019 were enrolled in the training cohort and the validation cohort, respectively. A total of 132 patients in the Beilun branch of the First Affiliated Hospital of Zhejiang University from January 2015 to August 2019 were enrolled in external validation cohorts. The nomogram was based on parameters determined by univariate and multivariate logistic analyses. The prediction performance of the nomogram was measured by the area under the receiver operating characteristic curve (AUROC), the calibration curve, and decision curve analysis (DCA). The applicability of the nomogram was internally and independently validated.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The predictors included the Eastern Cooperative Oncology Group Performance Status (ECOG), presence of an active cancer (AC), central venous catheter (CVC), and D-dimer levels. These risk factors are shown on the nomogram and verified. The nomogram demonstrated good discrimination and fine calibration with an AUROC of 0.875 (0.832 in internal validation and 0.807 in independent validation). The DCA revealed that the nomogram had a high clinical application value.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> We propose the nomogram for predicting TE in patients with GC receiving chemotherapy, which can help in making timely personalized clinical decisions for different risk populations.<\/jats:p>","DOI":"10.3389\/fonc.2021.598116","type":"journal-article","created":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T06:43:55Z","timestamp":1622011435000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["A Nomogram for Predicting Risk of Thromboembolism in Gastric Cancer Patients Receiving Chemotherapy"],"prefix":"10.3389","volume":"11","author":[{"given":"Hai-Liang","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Wei","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Ping","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Quan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Jing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1182\/blood-2013-04-460121","article-title":"Epidemiology of cancer-associated venous thrombosis","volume":"122","author":"Timp","year":"2013","journal-title":"Blood."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e1001275","DOI":"10.1371\/journal.pmed.1001275","article-title":"Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis","volume":"9","author":"Horsted","year":"2012","journal-title":"PLoS Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.thromres.2015.06.036","article-title":"Characteristics and risk factors of cancer associated venous thromboembolism","volume":"136","author":"Faiz","year":"2015","journal-title":"Thromb Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.amjmed.2017.12.015","article-title":"Predictors and outcomes of recurrent venous thromboembolism in elderly patients","volume":"131","author":"Lauber","year":"2018","journal-title":"Am J Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1001\/archinte.166.4.458","article-title":"Incidence of venous thromboembolism and its effect on survival among patients with common cancers","volume":"166","author":"Chew","year":"2006","journal-title":"Arch Intern Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/j.1538-7836.2007.02374.x","article-title":"Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy","volume":"5","author":"Khorana","year":"2007","journal-title":"J Thromb Haemost."},{"key":"B7","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1016\/j.thromres.2018.01.028","article-title":"Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancer","volume":"164","author":"Lyman","year":"2018","journal-title":"Thromb Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2018","journal-title":"Int J Cancer."},{"key":"B10","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","article-title":"Development and validation of a predictive model for chemotherapy-associated thrombosis","volume":"111","author":"Khorana","year":"2008","journal-title":"Blood."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","article-title":"Nomograms in oncology: more than meets the eye","volume":"16","author":"Balachandran","year":"2015","journal-title":"Lancet Oncol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12967-019-1861-z","article-title":"Pretreatment risk management of a novel nomogram model for prediction of thoracoabdominal extrahepatic metastasis in primary hepatic carcinoma","volume":"17","author":"Hu","year":"2019","journal-title":"J Transl Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.3389\/fonc.2020.01393","article-title":"Radiomics analysis of multiparametric MRI for the preoperative prediction of lymph node metastasis in cervical cancer","volume":"10","author":"Hou","year":"2020","journal-title":"Front Oncol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1111\/jgh.15004","article-title":"Risk factors and a predictive nomogram for lymph node metastasis of superficial esophagogastric junction cancer","volume":"35","author":"Zhu","year":"2020","journal-title":"J Gastroenterol Hepatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/jan.14571","article-title":"Development and validation of a risk assessment nomogram for venous thromboembolism associated with hospitalized postoperative Chinese breast cancer patients","volume":"77","author":"Li","year":"2020","journal-title":"J Adv Nurs"},{"key":"B16","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s11239-015-1309-0","article-title":"Guidance for the treatment and prevention of obstetric-associated venous thromboembolism","volume":"41","author":"Bates","year":"2016","journal-title":"J Thromb Thrombolysis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/bimj.201700067","article-title":"Variable selection\u2014a review and recommendations for the practicing statistician","volume":"60","author":"Heinze","year":"2018","journal-title":"Biom J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/ejcts\/ezy403","article-title":"Statistical primer: multivariable regression considerations and pitfalls","volume":"55","author":"Grant","year":"2019","journal-title":"Eur J Cardiothorac Surg."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1080\/10543406.2011.629890","article-title":"Stability investigations of multivariable regression models derived from low- and high-dimensional data","volume":"21","author":"Sauerbrei","year":"2011","journal-title":"J Biopharm Stat."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","article-title":"How to build and interpret a nomogram for cancer prognosis","volume":"26","author":"Iasonos","year":"2008","journal-title":"J Clin Oncol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Making."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1002\/cncr.23062","article-title":"Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients","volume":"110","author":"Khorana","year":"2007","journal-title":"Cancer."},{"key":"B23","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/cncr.23524","article-title":"Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients","volume":"113","author":"Gomez","year":"2008","journal-title":"Cancer."},{"key":"B24","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1016\/S0049-3848(17)30061-0","article-title":"Gender differences in patients with venous thromboembolism and five common sites of cancer","volume":"151","author":"Mart\u00edn-Martos","year":"2017","journal-title":"Thromb Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.6004\/jnccn.2018.0084","article-title":"NCCN guidelines insights: cancer-associated venous thromboembolic disease, version 2","volume":"16","author":"Streiff","year":"2018","journal-title":"J Natl Compr Canc Netw."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1002\/ajh.25603","article-title":"Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score","volume":"94","author":"Sanfilippo","year":"2019","journal-title":"Am J Hematol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.ejca.2012.10.021","article-title":"Incidence of venous thromboembolism in patients with cancer\u2014a cohort study using linked United Kingdom databases","volume":"49","author":"Walker","year":"2013","journal-title":"Eur J Cancer."},{"key":"B28","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.thromres.2016.01.002","article-title":"Risk factors for incident venous thromboembolism in active cancer patients: a population based case-control study","volume":"139","author":"Ashrani","year":"2016","journal-title":"Thromb Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.3892\/ijo.2018.4354","article-title":"Phosphatidylserine-exposing cells contribute to the hypercoagulable state in patients with multiple myeloma","volume":"52","author":"Guo","year":"2018","journal-title":"Int J Oncol"},{"key":"B30","first-page":"1435","article-title":"[Hypercoagulable State in Cancer]","volume":"63","author":"Yamashita","year":"2015","journal-title":"Rinsho Byori"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3870","DOI":"10.1200\/JCO.2011.40.1810","article-title":"Tumor grade is associated with venous thromboembolism in patients with cancer: results from the vienna cancer and thrombosis study","volume":"30","author":"Ahlbrecht","year":"2012","journal-title":"J Clin Oncol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1002\/jso.24220","article-title":"Peripherally inserted central catheters (PICCs) in cancer patients under chemotherapy: a prospective study on the incidence of complications and overall failures","volume":"113","author":"Bertoglio","year":"2016","journal-title":"J Surg Oncol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3109\/10428194.2013.813503","article-title":"Venous access catheter-related thrombosis in patients with cancer","volume":"55","author":"Gaddh","year":"2014","journal-title":"Leuk Lymphoma."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e015231","DOI":"10.1136\/bmjopen-2016-015231","article-title":"Determinants of treatment duration in the prevention of recurrent venous thromboembolism: a protocol for a balanced vignette experiment","volume":"7","author":"Ten","year":"2017","journal-title":"BMJ Open."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e289","DOI":"10.1016\/S2352-3026(18)30063-2","article-title":"A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts","volume":"5","author":"Pabinger","year":"2018","journal-title":"Lancet Haematol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.urolonc.2018.03.003","article-title":"Postoperative D-dimer predicts venous thromboembolism in patients undergoing urologic tumor surgery","volume":"36","author":"Shi","year":"2018","journal-title":"Urol Oncol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3892\/ol.2012.970","article-title":"Elevated preoperative plasma D-dimer levels and the incidence of venous thromboembolism in Japanese females with gynecological cancer","volume":"5","author":"Kodama","year":"2013","journal-title":"Oncol Lett."},{"key":"B38","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1097\/MBC.0b013e32835e63b7","article-title":"Blood clotting activation analysis for preoperative differentiation of benign versus malignant ovarian masses","volume":"24","author":"Amirkhosravi","year":"2013","journal-title":"Blood Coagul Fibrin."},{"key":"B39","doi-asserted-by":"publisher","first-page":"5169","DOI":"10.2147\/CMAR.S256484","article-title":"Risk factors and clinical significance of D-dimer in the development of postoperative venous thrombosis in patients with lung tumor","volume":"12","author":"Wang","year":"2020","journal-title":"Cancer Manag Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.1007\/s00520-015-2923-2","article-title":"The level of association between functional performance status measures and patient-reported outcomes in cancer patients: a systematic review","volume":"23","author":"Atkinson","year":"2015","journal-title":"Support Care Cancer."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1200\/JCO.2008.20.2879","article-title":"Pooled safety and efficacy analysis examining the effect of performance status on outcomes in nine first-line treatment trials using individual data from patients with metastatic colorectal cancer","volume":"27","author":"Sargent","year":"2009","journal-title":"J Clin Oncol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1053\/clon.2001.9256","article-title":"How accurate are physicians' clinical predictions of survival and the available prognostic tools in estimating survival times in terminally III cancer patients? A systematic review","volume":"13","author":"Chow","year":"2001","journal-title":"Clin Oncol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/6186543","article-title":"Moving beyond Karnofsky and ECOG performance status assessments with new technologies","volume":"2016","author":"Kelly","year":"2016","journal-title":"J Oncol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3892\/etm.2012.644","article-title":"First-line single-agent chemotherapy for patients with recurrent or metastatic gastric cancer with poor performance status","volume":"4","author":"Hwang","year":"2012","journal-title":"Exp Ther Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1093\/annonc\/mdp583","article-title":"Bone metastasis and poor performance status are prognostic factors for survival of carcinoma of unknown primary site in patients treated with systematic chemotherapy","volume":"21","author":"Kodaira","year":"2010","journal-title":"Ann Oncol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1186\/s12885-019-6155-6","article-title":"Sarcomatoid carcinoma presenting as cancers of unknown primary: a clinicopathological portrait","volume":"19","author":"Huey","year":"2019","journal-title":"BMC Cancer."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e014661","DOI":"10.1136\/bmjopen-2016-014661","article-title":"Treatment targeted at underlying disease versus palliative care in terminally ill patients: a systematic review","volume":"7","author":"Reljic","year":"2017","journal-title":"BMJ Open."},{"key":"B48","doi-asserted-by":"publisher","first-page":"5077","DOI":"10.21873\/anticanres.13701","article-title":"Performance status and its changes predict outcome for patients with inoperable stage III NSCLC undergoing multimodal treatment","volume":"39","author":"Kasmann","year":"2019","journal-title":"Anticancer Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3332\/ecancer.2018.831","article-title":"Palliative chemotherapy outcomes in patients with ECOG-PS higher than 1","volume":"12","author":"Caires-Lima","year":"2018","journal-title":"Ecancermedicalscience."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1007\/s00520-015-3031-z","article-title":"Chemotherapy at end-of-life: an integration of oncology and palliative team","volume":"24","author":"Chan","year":"2016","journal-title":"Support Care Cancer."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e028563","DOI":"10.1136\/bmjopen-2018-028563","article-title":"Incidence of cancer-associated thromboembolism in Japanese gastric and colorectal cancer patients receiving chemotherapy: a single-institutional retrospective cohort analysis (Sapporo CAT study)","volume":"9","author":"Aonuma","year":"2019","journal-title":"BMJ Open."},{"key":"B52","doi-asserted-by":"publisher","first-page":"W1","DOI":"10.7326\/M14-0697","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"162","author":"Moons","year":"2015","journal-title":"Ann Intern Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12916-018-1099-2","article-title":"Poor reporting of multivariable prediction model studies: towards a targeted implementation strategy of the TRIPOD statement","volume":"16","author":"Heus","year":"2018","journal-title":"BMC Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"294","DOI":"10.7326\/0003-4819-157-4-201208210-00014","article-title":"Beyond the usual prediction accuracy metrics: reporting results for clinical decision making","volume":"157","author":"Localio","year":"2012","journal-title":"Ann Intern Med."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.598116\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T06:43:58Z","timestamp":1622011438000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.598116\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,26]]},"references-count":54,"alternative-id":["10.3389\/fonc.2021.598116"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.598116","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,26]]},"article-number":"598116"}}